[
Chem Biol,
2015]
Rising antibiotic resistance means that alternative antibacterial strategies are sorely needed. In this issue, Zhu etal. (2015) report the use of a Caenorhabditis elegans model to validate the Pseudomonas aeruginosa virulence factor LasB as a potential therapeutic target and to identify a LasB inhibitor with invivo efficacy.